Achalasia and Dysplasia
Screening for Dysplasia in Longstanding Idiopathic Achalasia: a Prospective Study
1 other identifier
interventional
39
1 country
1
Brief Summary
Patient with achalasia have a 10-50 fold increased risk to develop esophageal squamous cell carcinoma (ESCC). Early diagnosis of ESCC is essential, and detection of an earlier dysplastic stage is preferred. Endoscopic detection is however difficult and often delayed. Chromoendoscopy with Lugol dye increases detection rates dysplasia and ESCC to 91-100%. The aim of this study was therefore to evaluate a screening program using chromoendoscopy with Lugol to detect dysplasia in patients with idiopathic achalasia. A second objective is to study the relationship between foodstasis and the development op dysplasia
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P25-P50 for not_applicable
Started Oct 2013
Typical duration for not_applicable
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
First Submitted
Initial submission to the registry
February 14, 2013
CompletedStudy Start
First participant enrolled
October 1, 2013
CompletedFirst Posted
Study publicly available on registry
December 13, 2013
CompletedPrimary Completion
Last participant's last visit for primary outcome
December 19, 2016
CompletedStudy Completion
Last participant's last visit for all outcomes
December 19, 2016
CompletedMarch 20, 2026
March 1, 2026
3.2 years
February 14, 2013
March 19, 2026
Conditions
Outcome Measures
Primary Outcomes (1)
incidence of dysplasia in patients with longstanding achalasia
1 year
Secondary Outcomes (2)
additive value of chromoendoscopy in comparison with lugol stain
1 year
relationship between food stasis and dysplasia
1 year
Study Arms (1)
longstanding achalasia
EXPERIMENTALInterventions
Eligibility Criteria
You may qualify if:
- longstanding achalasia (\> 15y)
- \> 18y old
- informed consent
You may not qualify if:
- allergy to iodine
- esophageal carcinoma
Contact the study team to confirm eligibility.
Sponsors & Collaborators
- KU Leuvenlead
Study Sites (1)
UZleuven
Leuven, 3000, Belgium
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- NA
- Purpose
- DIAGNOSTIC
- Intervention Model
- SINGLE GROUP
- Sponsor Type
- OTHER
- Responsible Party
- PRINCIPAL INVESTIGATOR
- PI Title
- Prof. Dr.
Study Record Dates
First Submitted
February 14, 2013
First Posted
December 13, 2013
Study Start
October 1, 2013
Primary Completion
December 19, 2016
Study Completion
December 19, 2016
Last Updated
March 20, 2026
Record last verified: 2026-03